Mohammadreza Ziavand

Dr. Mohammadreza Ziavand

orcid
Hygiene & Food safety / Tabriz university of medical science

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 January 2025 in Probiotics and Antimicrobial Proteins
Verified
Journal Article
Closed access
PDF file
NKNader Khani
Nader Khani
ASAmir Hesam Shakeri
Amir Hesam Shakeri
SHSousan Houshmandi
Sousan Houshmandi
Mohammadreza ZiavandMohammadreza Ziavand
Mohammadreza Ziavand
RSRoya Abedi Soleimani
Roya Abedi Soleimani
Aziz Homayouni-RadAziz Homayouni-Rad
Aziz Homayouni-Rad

7 November 2023 in Probiotics and Antimicrobial Proteins
Verified
Journal Article
Closed access
PDF file
NKNader Khani
Nader Khani
GNGhasem Noorkhajavi
Ghasem Noorkhajavi
RRReza Hazrati Reziabad
Reza Hazrati Reziabad
Aziz Homayouni-RadAziz Homayouni-Rad
Aziz Homayouni-Rad
Mohammadreza ZiavandMohammadreza Ziavand
Mohammadreza Ziavand

14 May 2026 in Clinical Microbiology Newsletter
Verified
Journal Article
Closed access
Mohammadreza ZiavandMohammadreza Ziavand
Mohammadreza Ziavand
NKNader Khani
Nader Khani
RSRoya Abedi Soleimani
Roya Abedi Soleimani
SSSeyed Mohamad Javad Shkouhian
Seyed Mohamad Javad Shkouhian
Aziz Homayouni-RadAziz Homayouni-Rad
Aziz Homayouni-Rad

13 February 2026 in Exploration of Immunology
Verified
Journal Article
Open access
PDF file
RSRoya Abedi Soleimani
Roya Abedi Soleimani
JHJalil Houshyar
Jalil Houshyar
SVSima Vadaei
Sima Vadaei
SASoheila Abachi
Soheila Abachi
PMPayam Gonbari Milani
Payam Gonbari Milani
Aziz Homayouni-RadAziz Homayouni-Rad
Aziz Homayouni-Rad
For decades, vaccines have been a key tool against microbial infections. However, the high cost of production and purification renders vaccines largely inaccessible to many developing countries. The limitations of conventional vaccines can be overcome by edible vaccines. To produce an oral vaccine, favourable vectors, such as plants and probiotics, are used. Recent studies have revealed the immunomodulatory effects of probiotics. To improve the efficacy of these vaccines, several adjuvant approaches have been employed. Postbiotics can be used as promising therapy for preventing infections and enhancing the host immune system due to their unique biochemical and microbial-derived properties. In this review, we discuss the feasibility of postbiotics as adjuvants for oral vaccines, highlighting their mechanisms of action, safety profile, and potential to enhance both mucosal and systemic immune responses.

30 October 2026 in Foods
Verified
Journal Article
Open access
PDF file
NKNader Khani
Nader Khani
SRShadi Rajabi
Shadi Rajabi
Mohammadreza ZiavandMohammadreza Ziavand
Mohammadreza Ziavand
RSRoya Abedi Soleimani
Roya Abedi Soleimani
SSSeyed Mohamad Javad Shokouhian
Seyed Mohamad Javad Shokouhian
Aziz Homayouni-RadAziz Homayouni-Rad
Aziz Homayouni-Rad
Microplastics (MPs), particularly those composed of polystyrene (PS), pose significant toxicological risks to humans, especially through oral exposure. Increasing evidence suggests that MPs contribute to the development of inflammatory bowel disease (IBD). Postbiotics have recently gained attention for their protective effects against various chemical pollutants, including MPs. They can alleviate MP-induced IBD through several mechanisms, such as anti-inflammatory activity, immunomodulatory effects, inhibition of pathogenic bacterial growth, and maintenance of intestinal barrier integrity. This review highlights the definitions of postbiotics, as well as their biological roles in the prevention and treatment of microplastics-induced inflammatory bowel disease.